Find information on thousands of medical conditions and prescription drugs.

Metadate


Metadate is Prescribed Medicine for Patients suffering from ADD.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
Macrodantin
Maprotiline
Marcaine
Marezine
Marijuana
Marinol
Marplan
Matulane
Maxair
Maxalt
Maxolon
MDMA
Measurin
Mebendazole
Mebendazole
Meclofenoxate
Medrol
Mefenamic acid
Mefloquine
Melagatran
Melarsoprol
Meloxicam
Melphalan
Memantine
Metadate
Metamfetamine
Metamizole sodium
Metandienone
Metaxalone
Metenolone
Metformin
Methadone
Methamphetamine
Methaqualone
Metharbital
Methcathinone
Methenamine
Methionine
Methocarbamol
Methohexital
Methotrexate
Methotrexate
Methoxsalen
Methylcellulose
Methyldopa
Methylergometrine
Methylin
Methylphenidate
Methylphenobarbital
Methylprednisolone
Methyltestosterone
Methysergide
Metiamide
Metoclopramide
Metohexal
Metoprolol
Metrogel
Metronidazole
Metyrapone
Mobic
Moclobemide
Modafinil
Modicon
Monopril
Montelukast
Motrin
Moxidectin
Moxifloxacin
Moxonidine
MS Contin
Mucinex
Mucomyst
Mupirocin
Mupirocin
Muse
Mycitracin
Mycostatin
Myfortic
Mykacet
Mykinac
Myleran
Mylotarg
Mysoline
Phentermine
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Use dosage designations
From Nurse Practitioner, 8/1/02 by Cohen, Hedy

Safe Prescribing

Confusion seems to reign whenever a drug is available in oral forms with different release rates. And, when two or more delayed-release forms exist for the same product, the confusion doubles. The ISMP has learned of four cases where pharmacists dispensed Metadate ER instead of Metadate CD. Although both drugs are extended-release formulations of methylphenidate hydrochloride, they aren't substitutable.

The CD product, a daily capsule with biphasic release, provides an initial rapid release of methylphenidate, then a continuous release phase, resulting in daylong control of attention deficit hyperactivity disorder symptoms. The ER product, a tablet, is given b.i.d. to t.i.d. None of the pharmacists involved in the error knew

The authors of Safe Prescribing are the following staff from the Institute for Safe Medication Practices (ISMP): Hedy Cohen, RN, BSN, vice-president nursing; Judy Smetzer, RN, BSN, director, risk management; and Michael Cohen, RPh, MS, FASHP, president ISMP, a nonprofit organization, derives its reports from the USP Medication Errors Reporting Program. To report medication errors, call the USP at 1-800-23-ERROR (233-7767). To contact ISMP, call 215-947-7797 or e-mail ismpinfo@ismp.org.

Copyright Springhouse Corporation Aug 2002
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Metadate
Home Contact Resources Exchange Links ebay